Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease

touchPODCAST

Content provided by touchpodcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by touchpodcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

2d ago 36:07

MP3•Episode home

touchEXPERT FOCUS for touchONCOLOGY

Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.

The experts:

Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
Prof. Peter Schmid – Barts Cancer Institute, London, UK

This touchPODCAST is for healthcare professionals outside of the UK.

This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website:

https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/

496 episodes

#Science #TouchPODCAST